ACIU — AC IMMUNE SA
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About AC IMMUNE SA (ACIU)
AC IMMUNE SA (ACIU) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $3M. Across recent filings, tracked investors recorded 5 new positions, 2 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ACIU
How many top investors track ACIU
A small number of top investors own this.
ACIU Ownership Composition
How AC IMMUNE SA is held across tracked investor types, based on reported 13F positions.
- Other78.8%
- Hedge Funds21.2%
Tracked investors reporting ACIU
- Izzy EnglanderMar 31, 2026Millennium ManagementShares792.7KValue$2.2M% Portfolio0.00%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares293.2KValue$806.3K% Portfolio0.00%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares298.2KValue$820.1K% Portfolio0.00%
Recent activity
- $2.9MFeb 17, 2026
- $2.2MMay 15, 2026
- New$1.3MFeb 17, 2026
- Increased$820.1K(124.15%)May 15, 2026
- New$806.3KMay 15, 2026
- Increased$417.8K(212.23%)Feb 17, 2026
- New$123.2KNov 14, 2025
Frequently asked questions
- How many institutional investors hold ACIU?
- 3 tracked institutional investors disclosed a position in ACIU (AC IMMUNE SA) in their most recent 13F filing.
- Who is the largest institutional holder of ACIU?
- Izzy Englander, Millennium Management, holds the largest disclosed position in ACIU, valued at $3M.
- Did institutional ownership of ACIU increase or decrease?
- Across recent 13F filings, tracked investors recorded 5 new positions, 2 increased, 0 reduced, and 0 fully exited ACIU.
- Where does this ACIU ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.